Dr Shahid Uddin | Head Of Formulation
MedImmune Cambridge

Shahid Uddin is Head of Formulation sciences at MedImmune Cambridge (MedImmune is the biologics arm of AstraZeneca). He joined the company when it was known as Cambridge Antibody Technology after holding research posts in several start up biotech companies specialising in polyclonal antibody therapeutics.  In his current role he is responsible for development for antibody and peptide and therapeutics, encompassing new novel formats.  His experience involves both early stage formulation development as well as late stage development as both liquid and lyophilized presentations. His group also have experience of several types of drug delivery technologies. Currently his team is set up to support up to phase II clinical studies then projects are transferred to the US group for commercialization.